#Shutdown thrusts Gossamer Bio onto a rarely used path for fixed-price IPO ? via @Endpts News

From day 1 Gos?samer has al?ways been a biotech in a hurry. And they?re not about to let a lit?tle thing like a gov?ern?ment shut?down stymy their plans for an IPO.

Source: Shutdown thrusts Gossamer Bio onto a rarely used path for fixed-price IPO ? Endpoints News